Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | CRHBP | P24387 | 1/20 | 0.43 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10792134 | 1.00 | TDP1 (0.47) | TDP1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL9695685 | 1.00 | TDP1 (0.47) | TDP1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL9328294 | 1.00 | TDP1 (0.47) | TDP1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL1702872 | 1.00 | TDP1 (0.47) | TDP1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL9697656 | 1.00 | TDP1 (0.47) | TDP1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL1703436 | 1.00 | TDP1 (0.47) | TDP1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL4089564 | 1.00 | TDP1 (0.47) | TDP1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL15727419 | 0.98 | TDP1 (0.49) | TDP1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL550001 | 0.92 | TDP1 (0.45) | TDP1KMT2AMEN1L3MBTL1MAPT | |
| SCHEMBL27877640 | 0.92 | TDP1 (0.45) | TDP1KMT2AMEN1L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110605-B2 | Compound for inactivating viruses and bacteria and method of making same | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-02-07 | — | — | US | disclosed |
| JP-2011020994-A | MEDICINE FOR BREAKING VIRUS AND BACTERIUM AND SUPPRESSING CONTAGION AND GROWTH OF THE SAME AND METHOD | NATIONAL TAIWAN UNIV | 2011-02-03 | — | — | JP | disclosed |
| US-20110015435-A1 | COMPOUND FOR INACTIVATING VIRUSES AND BACTERIA AND METHOD OF MAKING SAME | NATIONAL TAIWAN UNIVERSITY (TW) | 2011-01-20 | — | — | US | disclosed |
| EP-0422538-B1 | Malonic acid dyestuffs and products of their polycondensation | BASF AG (DE) | 1994-03-09 | — | — | EP | disclosed |
| US-5162545-A | Liquid crystals; laser optical writing; optical recording media | BASF AKTIENGESELLSCHAFT (DE) | 1992-11-10 | — | — | US | disclosed |
| EP-0422538-A1 | Malonic acid dyestuffs and products of their polycondensation | BASF Aktiengesellschaft (DE) | 1991-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015435-A1 | COMPOUND FOR INACTIVATING VIRUSES AND BACTERIA AND METHOD OF MAKING SAME | MGMT, CMBL, HAVCR2 | TDP1 3038/4885KMT2A 3121/4885MEN1 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.